Wellington Shields Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $709K | Sell |
1,442
-42
| -3% | -$22.8K | 0.11% | 130 |
|
|
2025
Q4 | $860K | Buy |
1,484
+93
| +7% | +$52.6K | 0.13% | 118 |
|
|
2025
Q3 | $675K | Sell |
1,391
-5
| -0.4% | -$2.33K | 0.1% | 130 |
|
|
2025
Q2 | $566K | Sell |
1,396
-15,685
| -92% | -$6.56M | 0.1% | 142 |
|
|
2025
Q1 | $8.5M | Sell |
17,081
-600
| -3% | -$325K | 1.54% | 16 |
|
|
2024
Q4 | $9.2M | Sell |
17,681
-530
| -3% | -$291K | 1.63% | 14 |
|
|
2024
Q3 | $11.3M | Buy |
18,211
+30
| +0.2% | +$17.8K | 1.96% | 11 |
|
|
2024
Q2 | $10.1M | Sell |
18,181
-10
| -0.1% | -$5.73K | 1.83% | 12 |
|
|
2024
Q1 | $10.6M | Sell |
18,191
-259
| -1% | -$145K | 1.99% | 10 |
|
|
2023
Q4 | $9.79M | Buy |
18,450
+1,200
| +7% | +$581K | 1.22% | 10 |
|
|
2023
Q3 | $8.73M | Hold |
17,250
| – | – | 1.15% | 10 |
|
|
2023
Q2 | $9M | Sell |
17,250
-144,093
| -89% | -$77.8M | 1.1% | 11 |
|
|
2023
Q1 | $10.1M | Buy |
161,343
+6,225
| +4% | +$3.51M | 1.21% | 8 |
|
|
2022
Q4 | $9.74M | Buy |
155,118
+9,669
| +7% | +$5.12M | 1.18% | 8 |
|
|
2022
Q3 | $9.59M | Sell |
145,449
-8,778
| -6% | -$4.91M | 2.28% | 8 |
|
|
2022
Q2 | $10.1M | Sell |
154,227
-11,908
| -7% | -$6.55M | 1.26% | 10 |
|
|
2022
Q1 | $11.1M | Buy |
166,135
+147,603
| +796% | +$84.8M | 1.21% | 11 |
|
|
2021
Q4 | $12.4M | Sell |
18,532
-206
| -1% | -$129K | 1.58% | 12 |
|
|
2021
Q3 | $10.7M | Buy |
18,738
+36
| +0.2% | +$19.8K | 1.46% | 13 |
|
|
2021
Q2 | $9.44M | Hold |
18,702
| – | – | 1.14% | 15 |
|
|
2021
Q1 | $8.54M | Sell |
18,702
-20
| -0.1% | -$9.55K | 0.81% | 22 |
|
|
2020
Q4 | $8.72M | Buy |
18,722
+42
| +0.2% | +$19.7K | 1.17% | 15 |
|
|
2020
Q3 | $8.25M | Sell |
18,680
-45
| -0.2% | -$18.6K | 1.31% | 11 |
|
|
2020
Q2 | $6.79M | Hold |
18,725
| – | – | 1.09% | 17 |
|
|
2020
Q1 | $5.31M | Hold |
18,725
| – | – | 1% | 17 |
|
|
2019
Q4 | $6.08M | Buy |
18,725
+400
| +2% | +$121K | 0.93% | 21 |
|
|
2019
Q3 | $5.34M | Buy |
18,325
+900
| +5% | +$258K | 0.87% | 22 |
|
|
2019
Q2 | $5.12M | Buy |
17,425
+3,985
| +30% | +$1.1M | 0.85% | 18 |
|
|
2019
Q1 | $3.68M | Buy |
13,440
+360
| +3% | +$89.6K | 0.63% | 31 |
|
|
2018
Q4 | $2.93M | Sell |
13,080
-1,500
| -10% | -$352K | 0.55% | 37 |
|
|
2018
Q3 | $3.56M | Buy |
14,580
+1,170
| +9% | +$269K | 0.57% | 35 |
|
|
2018
Q2 | $2.78M | Buy |
13,410
+2,155
| +19% | +$457K | 0.46% | 44 |
|
|
2018
Q1 | $2.32M | Buy |
11,255
+6,150
| +120% | +$1.29M | 0.35% | 65 |
|
|
2017
Q4 | $969K | Buy |
+5,105
| New | +$978K | 0.15% | 138 |
|
Other funds holding TMO
VCM
Wellington Shields Capital Management's TMO Position: Q1 2026 in Review
Wellington Shields Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 2.8% in Q1 2026, selling an estimated $22.8K and leaving 1,442 shares worth $709K. The position accounts for 0.11% of the portfolio, ranked #130.
Wellington Shields Capital Management first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. The position peaked at $12.4M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Wellington Shields Capital Management held 1,442 shares of Thermo Fisher Scientific worth $709K as of Q1 2026.
- Wellington Shields Capital Management sold 42 Thermo Fisher Scientific shares in Q1 2026, an estimated $22.8K.
- Thermo Fisher Scientific made up 0.11% of Wellington Shields Capital Management's portfolio in Q1 2026, its #130 holding.
- Wellington Shields Capital Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
- Wellington Shields Capital Management's Thermo Fisher Scientific position peaked at $12.4M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Wellington Shields Capital Management's 13F filing for Q1 2026, filed 4 May 2026.